Pneumonitis after chemoradiation and adjuvant durvalumab in stage III non-small-cell lung cancer

Edwards DM, Sankar K, Alseri A, Jiang R, Schipper M, Miller S, Dess K, Strohbehn GW, Elliott DA, Moghanaki D, Ramnath N, Green MD, Bryant AK. Pneumonitis after chemoradiation and adjuvant durvalumab in stage III non-small-cell lung cancer. Int J Radiat Oncol Biol Phys. 2023 Oct 2:S0360-3016(23)07971-3. doi: 10.1016/j.ijrobp.2023.09.050. Epub ahead of print. PMID: 37793573.


Related Posts